Baird Medical Investment Holdings Ltd - Ordinary Shares, $0.0001 par value (BDMD)

CUSIP: G0705H103

Q3 2026 13F Holders as of 30 Sep 2026

Holder snapshot 3 signals
Share change
0
SEC-reported price per share
$0.75
Number of holders
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
35,554,234

Security key

G0705H103

Report period

Q3 2026

Institutions

1

Top holders

1

Ownership snapshot

Top reported holders of BDMD - Baird Medical Investment Holdings Ltd - Ordinary Shares, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ExcelFin SPAC LLC
Disclosed value leader
Haimei Wu
Comparable rows
3/15
Latest evidence
24 Sep 2026
13D/G 3/4/5 13F Lead comparable stake: 19% 12 rows are not safely comparable across share classes. 13D/G row: ExcelFin SPAC LLC Showing 1-6 of 15 holder rows.

Quick read

ExcelFin SPAC LLC leads the comparable SEC ownership view at 19%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ExcelFin SPAC LLC's linked filing trail.
Comparable ownership Top 3
ExcelFin SPAC LLC 19%
L1 Capital Global Opportunities M... 10%
Alta Partners LLC 5.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ExcelFin SPAC LLC
13D/G 3/4/5
Grand Fortune Capital (HK) Co Ltd · 10%+ Owner
19%
Reported 13D/G · 01 Oct 2024
$8,264,739
7,004,016 shares
$0 01 Oct 2024
L1 Capital Global Opportunities Master Fund, Ltd.
13D/G
10%
Reported 13D/G · 24 Sep 2026
$3,871,536
3,551,868 shares
$0 24 Sep 2026
Alta Partners LLC
13D/G
5.1%
Reported 13D/G · 05 May 2026
$3,512,263
1,995,604 shares
$0 05 May 2026
Haimei Wu
3/4/5
Director, 10%+ Owner
—
denominator unverified
$24,745,582
18,195,281 shares
— 27 Mar 2026
UBS Group AG
13F
Company
13F
—
mixed-class rows
$69,418
106,883 shares
mixed-class rows
— 30 Jun 2026
TWO SIGMA INVESTMENTS, LP
13F
Company
13F
—
denominator unverified
$63,825
55,500 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
1
Shares
19,596
Rows available
1
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q2 2026 Across Filers

Q2 2026 holders
10
Q3 2026 holders
1
Holder diff
-9
Investor Q2 2026 Shares Q3 2026 Shares Share Diff Share Chg % Q2 2026 value Q3 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .